Prostate Cancer is a peer-reviewed english-language open-access journal published by Wiley in United Kingdom, operating under an open-access model since 2011. The journal covers Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology and Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors are required to pay an article processing charge to publish in Prostate Cancer; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, Prostate Cancer has published 211 articles. Articles are minted with DOIs through the prefix 10.1155. All submissions undergo plagiarism screening before peer review.
Keywords
male urogenital diseases, prostatic neoplasms, prostate cancer
At a glance
- Publisher
- Wiley
- Country
- United Kingdom
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Anonymous peer review
- OA since
- 2011
- Review time
- 13 weeks
- DOI prefix
10.1155- Plagiarism check
- Yes
ISSN
- 2090-3111
- electronic
- 2090-312X
Frequently asked questions
Is Prostate Cancer peer-reviewed?
Does Prostate Cancer charge an article processing charge (APC)?
What subjects does Prostate Cancer publish?
What languages does Prostate Cancer accept?
What is the ISSN of Prostate Cancer?
2090-3111 (print) · 2090-312X (electronic).